In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 416-422

  Lacal, Pedro Miguel ^a,b   D'Atri, Stefania ^a   Orlando, Laura ^a   Bonmassar, Enzo ^a   Graziani, Grazia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; DACARBAZINE; MITOZOLOMIDE; SCH 52365; TEMOZOLOMIDE; TRIAZENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; DNA ADDUCT; DNA ALKYLATION; DNA REPAIR; ENZYME INACTIVATION; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; DNA; DRUG RESISTANCE; GUANINE; HUMANS; METHYLTRANSFERASES; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RECOMBINANT PROTEINS; SPODOPTERA; TRIAZENES; TUMOR CELLS, CULTURED;

EID: 0030433662     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. AAMDAL, S., GERARD, B., BOHMAN, T. AND D'INCALCI, M.: Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma - an effective combination with unexpected toxicity. Eur. J. Cancer 28: 447-450, 1992.
2. AYI, T. C., LOH, K. C., ALI, R. B., LI, B. F. L.: Intracellular localization of human DNA repair enzyme methylguanine-DNA methyltransferase by antibodies and its importance. Cancer Res. 52: 6423-6430, 1992.
3. 6-methylguanine-DNA methyltransferase and its possible application for monitoring human exposure to alkylating carcinogens. Cancer Res. 54: 3726-3731, 1994.
4. BALCH, C. M., HOUGHTON, A. AND PETERS, L.: Cutaneous melanoma. In Cancer: Principles and Practice of Oncology, ed. by V. T. DeVita, S. Hellman and S. A. Rosenberg, pp. 1612-1661, Lippincott, Philadelphia, PA, 1993.
5. BERETTA, G., BONADONNA, G., BAJETTA, E., TANCINI, G., DE LENA, M., AZZARELLI, A. AND VERONESI, U.: Combination chemotherapy with DTIC(NSC-45388) in advanced malignant melanoma, soft tissue sarcoma and Hodgkin's disease. Cancer Treat. Rep. 60: 205-211, 1976.
6. BONMASSAR, E., BONMASSAR, A., VADLAMUDI, S. & GOLDIN, A.: Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug. Proc. Natl. Acad. Sci. U.S.A. 66: 1089-1095, 1970.
7. BONO, V. H. JR.: Studies on the mechanism of action of DTIC (NSC-45388). Cancer Treat. Rep. 60: 141-148, 1976.
8. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
9. 6-alkylguanine-DNA alkyltransferase by alkylating agents or alkylated DNA. Cancer Res. 46: 2320-2323, 1986.
10. 6-alkylguanine-DNA alkyltransferase. J. Med. Chem. 37: 342-347, 1994.
11. 6-methylguanine-DNA methyltransferase. Arch. Biochem. Biophys. 300: 193-200, 1993.
12. 6-benzylguanine in vitro. Carcinogenesis 14: 1057-1060, 1993.
13. CHOMCZYNSKI, P. AND SACCHI, N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
14. CONNORS, T. A., GODDARD, P. M., MERAI, K., ROSS, W. C. J. AND WILMAN, D. E. V.: Tumor inhibitory triazenes: Structural requirements for an active metabolite. Biochem. Pharmacol. 25: 241-246, 1976.
15. 6-benzylguanine. Cancer Res. 54: 6221-6227, 1994.
16. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res. 51: 3367-3372, 1991.
17. ECKHARDT, S.: Clinical use of triazenes. In Triazenes, Chemical, Biological, and Clinical Aspects, ed. by T. Giraldi, T. A. Connors and G. Cartei, pp. 109-118, Plenum Press, New York, 1990.
18. 6-benzylguanine. Biochem. J. 298: 231-235, 1994.
19. 6-alkylguanine-DNA-alkyltransferase cDNA in human cells and transgenic mice. Nucleic Acids Res. 18: 5723-5727, 1990.
20. 6-benzylguanine and 1,3(2-chloroethyl)-1-nitrosourea. Cancer Chemother. Pharmacol. 32: 471-476, 1993.
21. 3H)-one. Cancer Res. 44: 1772-1775, 1984.
22. - phenotypes by a series of alkyltriazenylimidazoles. Carcinogenesis 7: 259-265, 1986.
23. 6-alkylguanine-DNA alkyltransferase by DNA. Biochemistry 33: 8385-8390, 1994.
24. GROHMANN, U., PUCCETTI, P., BELLADONNA, M. L., FALLARINO, F., BIANCHI, R., BINAGLIA, L., SAGAKUCHI, K., MAGE, M. G., APPELLA, E. AND FIORETTI, M. C.: Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor. J. Immunol. 154: 4630-4641, 1995.
25. HARDING, M., DOCHERTY, V. MACKIE, R., DORWARD, A. AND KAYE, S.: Phase II studies of mitozolomide in melanoma, lung and ovarian cancer. Eur. J. Cancer Clin. Oncol. 25: 785-788, 1989.
26. - cells. Cancer Res. 52: 6404-6406, 1992.
27. HATTORI, M. AND SAKAKI, Y.: Dideoxy sequencing method using denatured plasmid templates. Anal. Biochem. 152: 232-238, 1986.
28. 6-methylguanine in DNA. J. Mol. Biol. 213: 739-747, 1990.
29. ISHIBASHI, T., NAKABEPPU, Y., KAWATE, H., SAKUMI, K., HAYAKAWA, H. AND SEKIGUCHI, M.: Intracellular localization and function of DNA repair methyl-transferase in human cells. Mut. Res. 315: 199-212, 1994.
30. JULLIARD, M. AND VERNIN, G.: Biological properties of antitumor triazenes. Ind. Eng. Chem. Prod. Res. Dev. 20: 287-296, 1981.
31. 6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: The role of MGMT in protection against the genotoxic effects of alkylating agents. Carcinogenesis 12: 1857-1867, 1991.
32. 6-methylguanine-DNA methyltransferase. J. Biol. Chem. 265: 14754-14762, 1990.
33. 6-methylguanine repair mechanism in cultured rat hepatocytes. J. Toxicol. Environ. Health 43: 441-451, 1994.
34. LAEMMLI, U. K.: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
35. 6-alkylguanine DNA-alkyltransferase in human liver and melanoma. Br. J. Cancer 66: 355-360, 1992.
36. LEE, S. M., MARGISON, G. P., WOODCOCK, A. A. AND THATCHER, N.: Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma. Br. J. Cancer 67: 1356-1360, 1993.
37. 6-alkylguanine-DNA alkyltransferase in human peripheral leukocytes. Cancer Res. 54: 4072-4076, 1994a.
38. 6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide. Br. J. Cancer 69: 452-456, 1994b.
39. 6-benzylguanine, streptozotocin, and 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro and in vivo. Biochem. Pharmacol. 48: 2127-2134, 1994.
40. MARGISON, G. P., COOPER D. P. AND BRENNAN, J.: Cloning of the E. Coli O6-methylguanine and methylphosphotriester methyl transferase gene using a functional DNA repair assay. Nucleic Acids Res. 13: 1939-1952, 1985.
41. 6-methylguanine. Nucleic Acids Res. 18: 1351-1359, 1990.
42. MEER, L., JANZER, R. C., KLEIHUES, P. AND KOLAR, G. F.: In vivo metabolism and reaction with DNA of the cytostatic agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC). Biochem. Pharmacol. 35: 3243-3247, 1986.
43. MICETICH, K. C., FUTSCHER, B. W., KOCH, D., FISHER, R. I. AND ERICKSON, L. C.: A phase I study of streptozotocin and BCNU sequenced administration in patients with advanced cancer. J. Natl. Cancer Inst. 84: 256-260, 1992.
44. 6-alkylguanine-DNA alkyltransferase. Cancer Res. 53: 997-1003, 1993.
45. MITCHELL, R. B., DOLAN, M. E., JANISCH, L., VOGELZANG, N. J., RATAIN, M. J., SCHILSKY, R. L.: Sequential therapy with dacarbazine and carmustine: a phase I study. Cancer Chemother. Pharmacol. 34: 509-514, 1994.
46. NEWLANDS, E. S., BLACKLEDGE, G. R. P., SLACK, J. A., RUSTIN, G. J. S., SMITH, D. B., STUART, N. S. A., QUARTERMAN, C. P., HOFFMAN, R., STEVENS, M. F. G., BRAMPTON, M. H. AND GIBSON, A. C.: Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br. J. Cancer 65: 287-291, 1992.
47. O'REILLY, S. M., NEWLANDS, E. S., GLASER, M. G., BRAMPTON, M., RICE-EDWARDS, J. M., ILLINGWORTH, R. D., RICHARDS, P. G., KENNARD, C., COLQUHOUN, I. R., LEWIS, P. AND STEVENS, M. F. G.: Temozolomide: A new oral cytotoxic chemoterapeutic agent with promising activity against primary brain tumors. Eur. J. Cancer 29A: 940-942, 1993.
48. 6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotoein: A phase I trial. Cancer Res. 52: 2456-2459, 1992.
49. 6-alkylguanine. FASEB J. 6: 2302-2310, 1992.
50. 6-methylguanine-DNA methyltransferase activity and mRNA levels in HT-29 cells in vitro. Cancer Res. 51: 1581-1585, 1991.
51. PLOWMAN, J., WAUD, W. R., KOUTSOUKOIS, A. D., RUBINSTEIN, L. V., MOORE, T. D. AND GREVER, M. R.: Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-Bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 54: 3793-3799, 1994.
52. STEVENS, M. F. G., HICKMAN, J. A., STONE, R., GIBSON, N. W., LUNT, E., NEWTON, C. G. AND BAIG, G. U.: Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one, a novel broad-spectrum antitumor agent. J. Med. Chem. 27: 196-201, 1984.
53. STEVENS, M. F. G., HICKMAN, J. A., LANGDON, S. P., CHUBB, D., VICKERS, L., STONE, R., BAIG, G., GODDARD, C., GIBSON, N. W., SLACK, J. A., NEWTON, C., LUNT, E., FIZAMES, C. AND LAVELLE, F.: Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to Dacarbazine. Cancer Res. 47: 5846-5852, 1987.
54. SUMMERS, M. D. AND SMITH, G. E.: A manual of methods for baculovirus vectors and insect cell culture procedures, ed. by M. D. Summers and G. E. Smith, Texas Agricultural Experiment Station Bulletin 1555, College Station, TX, 1987.
55. TSANG, L. L. H., QUARTERMAN, C. P., GESCHER, A. AND SLACK, J. A.: Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide. Cancer Chemother. Pharmacol. 27: 342-346, 1991.
56. 6-alkylguanine-DNA alkyltransferase based on the crystal structure of the C-terminal domain of the Ada protein from Escherichia coli. Anticancer Drug Res. 10: 75-95, 1995.
57. WILMAN, D. E. V. AND GODDARD, P. M.: Tumour inhibitory triazenes. 2. Variation of antitumour activity within a homologous series. J. Med. Chem. 23: 1052-1054, 1980.
58. ZLOTOGORSKI, C. AND ERICKSON, L. C.: Pretreatment of human colon tumour cells with DNA methylating agents inhibits their ability to repair chloroethyl monoadducts. Carcinogenesis 5: 83-87, 1984.